Resources | NITAG RESOURCE CENTER

2023 ∙ Liu, Y. Kuang, K.

Predictors of COVID-19 vaccination hesitancy in China: a meta-analysis

2023 ∙ ATAGI

ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines

2023 ∙ ATAGI

ATAGI Update on the COVID-19 Vaccination Program

2023 ∙ ATAGI

ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older

2023 ∙ ATAGI

ATAGI 2023 booster advice

2023 ∙ ATAGI

ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine

2022 ∙ Xu, B. Zhu, Y.

A systematic review and meta-analysis of the factors associating the willingness of Chinese community residents to receive COVID-19 vaccine

2022 ∙ Ma, Y. Ren, J. Zheng, Y. Cai, D. Li, S. Li, Y.

Chinese parents' willingness to vaccinate their children against COVID-19: A systematic review and meta-analysis

2022 ∙ Shui, X. Wang, F. Li, L. Liang, Q.

COVID-19 vaccine acceptance among healthcare workers in China: A systematic review and meta-analysis

2022 ∙ Fu, Y. Zhao, J. Wei, X. Han, P. Yang, L. Ren, T. Zhan, S. Li, L.

Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies